vimarsana.com
Home
Live Updates
In Bevacizumab to Aflibercept Switch, Monitor For Risks - En
In Bevacizumab to Aflibercept Switch, Monitor For Risks - En
In Bevacizumab to Aflibercept Switch, Monitor For Risks - Endocrinology Advisor
Patients switching from bevacizumab to aflibercept for DME therapy should be evaluated for several risk factors.
Related Keywords
,
Retina Network Protocol ,
Network Protocol ,